# A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

> **NCT02636946** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 144 (actual)

## Conditions studied

- Glaucoma
- Open-Angle Ocular Hypertension

## Interventions

- **DRUG:** Bimatoprost SR
- **DRUG:** Sham Bimatoprost SR
- **PROCEDURE:** Selective Laser Trabeculoplasty
- **PROCEDURE:** Sham Selective Laser Trabeculoplasty

## Key facts

- **NCT ID:** NCT02636946
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-24
- **Primary completion:** 2021-01-26
- **Final completion:** 2021-01-26
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2022-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02636946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02636946, "A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02636946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*